KalVista Prices Upsized Offering of $125.0 Million of 3.250% Convertible Senior Notes Due 2031
-
最新报道：KalVista Pharmaceuticals has priced its $125 million private placement of 3.250% convertible senior notes due 2031, increasing the offering from the initially announced $110 million. The notes, which carry a conversion price of approximately $16.81 per share (representing a 30% premium over KalVista's last reported stock price of $12.93), will mature on October 1, 2031, and may be settled in shares, cash, or a combination upon conversion. The company also granted initial purchasers a 13-day option to buy up to an additional $18.75 million in notes.
下一篇
E&R Strengthens North American Semiconductor Presence with New U.S. Subsidiary
- E&R Engineering Corp. has launched its U.S. subsidiary in Phoenix, Arizona, to strengthen ...
24小时热点
热点专题
418154